COVID-19 Vaccine Patent Rules Reconsidered by World Trade Organization
TUESDAY, June 8, 2021 -- A proposal to ease patents and related protections on COVID-19 vaccines in order to help developing nations fight the pandemic will be considered at a two-day meeting of a World Trade Organization (WTO) panel.
The idea is backed by more than 60 countries, including the United States, but faces opposition from other wealthy nations with strong pharmaceutical sectors, the Associated Press reported.
At the meeting that begins Tuesday, the WTO panel will consider a revised proposal from India and South Africa for a temporary international property waiver on COVID-19 vaccines.
The European Union tabled an alternative proposal that relies on existing WTO rules that allow governments to grant production licenses to manufacturers in their countries without the consent of the patent holders in times of emergency, the AP reported.
© 2021 HealthDay. All rights reserved.
Posted June 2021
Further Support and Information on COVID-19
Read this next
FRIDAY, June 18, 2021 -- COVID-19 vaccination coverage is low among pregnant women in the United States, according to research published in the June 18 issue of the U.S. Centers...
FRIDAY, June 18, 2021 -- The ChAdOx1 COVID-19 vaccine is associated with a small increased risk for idiopathic thrombocytopenic purpura (ITP), according to a study published...
FRIDAY, June 18, 2021 -- The COVID-19 pandemic has contributed to worse mental health among adolescents, although there have been decreases in substance use, according to a study...
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.